Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Dolan

Showing results (121-130 of 188) with videos related to

Pageof 19
Sort By:
Human Molecular Genetics|December 16, 2011
An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markersYujia Wen, Eric R Gamazon, Wasim K Bleibel, et al.
American Journal of Human Genetics|August 19, 2007
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approachR Stephanie Huang, Shiwei Duan, Sunita J Shukla, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2005
Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanineMelissa L Fishel, Michael P Gamcsik, Shannon M Delaney, et al.
Pharmacogenetics and Genomics|June 16, 2009
Platinum pathwaySharon Marsh, Howard McLeod, Eileen Dolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2020
Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology GroupChristine L Phillips, Adam Lane, Robert B Gerbing, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2014
Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology GroupPatrick Thompson, Heather E Wheeler, Shannon M Delaney, et al.
Chemical Research in Toxicology|September 21, 2004
1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustardsJames B Springer, Young H Chang, Kyo I Koo, et al.
Pharmacogenetics and Genomics|June 11, 2009
Etoposide pathwayJun Yang, Alessia Bogni, Erin G Schuetz, et al.
Pharmacogenetics and Genomics|March 6, 2014
Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analysesHeather E Wheeler, Anna González-Neira, Guillermo Pita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trialJon Weingart, Stuart A Grossman, Kathryn A Carson, et al.
Pageof 19

Showing results (121-130 of 188) with videos related to

Sort By:
Pageof 19
Human Molecular Genetics|December 16, 2011
An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markersYujia Wen, Eric R Gamazon, Wasim K Bleibel, et al.
American Journal of Human Genetics|August 19, 2007
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approachR Stephanie Huang, Shiwei Duan, Sunita J Shukla, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2005
Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanineMelissa L Fishel, Michael P Gamcsik, Shannon M Delaney, et al.
Pharmacogenetics and Genomics|June 16, 2009
Platinum pathwaySharon Marsh, Howard McLeod, Eileen Dolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2020
Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology GroupChristine L Phillips, Adam Lane, Robert B Gerbing, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2014
Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology GroupPatrick Thompson, Heather E Wheeler, Shannon M Delaney, et al.
Chemical Research in Toxicology|September 21, 2004
1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustardsJames B Springer, Young H Chang, Kyo I Koo, et al.
Pharmacogenetics and Genomics|June 11, 2009
Etoposide pathwayJun Yang, Alessia Bogni, Erin G Schuetz, et al.
Pharmacogenetics and Genomics|March 6, 2014
Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analysesHeather E Wheeler, Anna González-Neira, Guillermo Pita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trialJon Weingart, Stuart A Grossman, Kathryn A Carson, et al.
Pageof 19